Milnubes / Curiosity, with sourcesBotany · Culture · Science
Cannabinoid atlas / Reference entry
2-AG
Endocannabinoids

2-Arachidonoylglycerol

2-AG offers a way to explore returning messages between neurons. Here we follow questions that help interpret them, without turning an interesting physiological explanation into advice for changing the body.

Two professionals review a tablet beside a man wearing a recording headset.
Stock photograph providing context for this entry. It does not document a trial, participant, identified product or 2-AG result.
Evidence map

Laboratory or animals. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.

How we read studies and personal accounts ↗

Identity

2-AG stands for 2-arachidonoylglycerol, a lipid endocannabinoid. A 1995 paper documented its binding to cannabinoid receptors in nervous-tissue preparations.

Terms associated with this entry: 2-arachidonoylglycerol, 2-araquidonoilglicerol.

What a returning message means

Here, “retrograde” describes the direction of communication at a synapse. It does not mean a disease is reversing or that a patient is improving. That vocabulary distinction matters: a familiar-sounding word can have a technical meaning that completely changes how a headline should be read.

Testing what happens when a piece is missing

In 2010, mice lacking DGLα lost the studied retrograde synaptic suppression in several brain regions; mice lacking DGLβ retained it. The comparison supported a specific role for DGLα and 2-AG.

This illustrates a causal question: rather than merely finding two things together, researchers change one component and observe the outcome. The conclusion must still retain its experimental setting. Explaining a nerve connection is different from demonstrating a beneficial intervention in patients.

Production when a signal is needed

A 2013 study supported on-demand synthesis of 2-AG.

Why “more” is not a sufficient goal

Judging a proposal to increase a signal requires context and an outcome: where, when and for what purpose? Explaining how a circuit works does not prescribe how to alter it. Confusing those levels turns an interesting observation into advice the experiment has not tested.

What has been studied

Risks and gaps

Documented forms

Endogenous messengerIts physiological description does not validate products bearing its name.

A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.

Experiences

We have not included a verifiable individual account in this review. We do not fill that gap with commercial stories or invented experiences.

Conclusion

The value of 2-AG in this encyclopedia is showing that the cannabinoid system has messages of its own. Understanding them helps us ask better questions without turning them into wellness products.

Legal context

Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.

Sources

  1. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain · Original research
  2. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission · Animal study
  3. Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol · Laboratory study

Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.